Ira R. Katz < Ira Shoulson < Iracema Leroi

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]

Ident.	Authors (with country if any)	Title
000089 (2009)	Bernard Ravina ; Caroline Tanner ; Diane Dieuliis ; Shirley Eberly ; Emily Flagg ; Wendy R. Galpern ; Stanley Fahn ; Christopher G. Goetz ; Stephen Grate ; Roger Kurlan ; Anthony E. Lang ; Kenneth Marek ; Karl Kieburtz ; David Oakes ; Robin Elliott ; Ira Shoulson	A longitudinal program for biomarker development in Parkinson's disease: A feasibility study
000131 (2008)	Christopher G. Goetz ; Joanne Wuu ; Michael P. Mcdermott ; Charles H. Adler ; Stanley Fahn ; Curt R. Freed ; Robert A. Hauser ; Warren C. Olanow ; Ira Shoulson ; P. K. Tandon ; Sue Leurgans	Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions
000832 (2006)	Kevin M. Biglan ; Steven Schwid ; Shirley Eberly ; Karen Blindauer ; Stanley Fahn ; Tamar Goren ; Karl Kieburtz ; David Oakes ; Sandra Plumb ; Andrew Siderowf ; Matthew Stern ; Ira Shoulson	Rasagiline improves quality of life in patients with early Parkinson's disease
000A39 (2009)	Connie Marras ; Anthony E. Lang ; Shirley W. Eberly ; David Oakes ; Stanley Fahn ; Steven R. Schwid ; Christopher Hyson ; Ira Shoulson	A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts
000B37 (1990)	Penney Jr. ; Anne B. Young ; Ira Shoulson ; Simon Starosta-Rubenstein ; S. Robert Snodgrass ; Juan Sanchez-Ramos ; Maria Ramos-Arroyo ; Fidela Gomez ; Graciela Penchaszadeh ; Jose Alvir ; Jesus Esteves ; Iris Dequiroz ; Nelson Marsol ; Humberto Moreno ; P. Michael Conneally ; Ernesto Bonilla ; Nancy S. Wexler	Huntington's disease in venezuela: 7 years of follow‐up on symptomatic and asymptomatic individuals
000C05 (2010)	Steven R. Schwid ; Janice Bausch ; David Oakes ; Lynn Schuchter ; Caroline Tanner ; Misser Forrest ; Anthony E. Lang ; Ira Shoulson	Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease
000E59 (2002)	Andrew Siderowf ; Michael Mcdermott ; Karl Kieburtz ; Karen Blindauer ; Sandra Plumb ; Ira Shoulson	Test–Retest reliability of the Unified Parkinson's Disease Rating Scale in patients with early Parkinson's disease: Results from a multicenter clinical trial
001331 (2011)	Ira Shoulson ; Anne B. Young	Milestones in Huntington disease
001380 (2011)	Connie Marras ; Michael P. Mcdermott ; Ken Marek ; Paula Rochon ; Gary Naglie ; Caroline M. Tanner ; Alice Rudolph ; Ira Shoulson ; Anthony E. Lang	Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts
001764 (2011)	Michael A. Schwarzschild ; Kenneth Marek ; Shirley Eberly ; David Oakes ; Ira Shoulson ; Danna Jennings ; John Seibyl ; Alberto Ascherio	Serum urate and probability of dopaminergic deficit in early “Parkinson's disease”
001883 (2005)	Penelope Hogarth ; Elise Kayson ; Karl Kieburtz ; Karen Marder ; David Oakes ; Diana Rosas ; Ira Shoulson ; Nancy S. Wexler ; Anne B. Young ; Hongwei Zhao	Interrater agreement in the assessment of motor manifestations of Huntington's disease
001B97 (2006)	J. Antonelle Demarcaida ; Steven R. Schwid ; William B. White ; Karen Blindauer ; Stanley Fahn ; Karl Kieburtz ; Matthew Stern ; Ira Shoulson	Effects of tyramine administration in Parkinson's disease patients treated with selective MAO‐B inhibitor rasagiline
001F08 (2008)	Bernard Ravina ; Megan Romer ; Radu Constantinescu ; Kevin Biglan ; Alicia Brocht ; Karl Kieburtz ; Ira Shoulson ; Michael P. Mcdermott	The relationship between CAG repeat length and clinical progression in Huntington's disease
002D90 (1997)	Como ; Allen J. Rubin ; Chris F. O'Brien ; Kathy Lawler ; Charlyne Hickey ; Ann E. Rubin ; Robin Henderson ; Michael P. Mcdermott ; Maria Mcdermott ; Kim Steinberg ; Ira Shoulson	A controlled trial of fluoxetine in nondepressed patients with Huntington's disease
002F54 (1996)	Kieburtz ; Andrew Feigin ; Michael Mcdermott ; Peter Como ; David Abwender ; Carol Zimmerman ; Charlyne Hickey ; Constance Orme ; Kathy Claude ; Jennie Sotack ; J. Timothy Greenamyre ; Cynthia Dunn ; Ira Shoulson	A controlled trial of remacemide hydrochloride in Huntington's disease
003347 (2010)	Ira Shoulson	Therapeutic directions for Parkinson's disease
003429 (1987)	Kurlan ; Jill Behr ; Ira Shoulson	Hereditary myoclonus and chorea: The spectrum of hereditary nonprogressive hyperkinetic movement disorders
003434 (1989)	Un Jung Kang ; Stanley Fahn ; Heidi Schwarz ; Ira Shoulson ; Humberto Vallejos ; James Goldman	Case 1, 1989: Juvenile‐onset parkinsonism, dystonia, and pyramidal tract signs
003554 (1995)	Feigin ; Karl Kieburtz ; Kathy Bordwell ; Peter Como ; Kimberly Steinberg ; Jenny Sotack ; Carol Zimmerman ; Charlyne Hickey ; Constance Orme ; Ira Shoulson	Functional decline in Huntington's disease
003828 (1987)	Kurlan ; Jill Behr ; Louis Medved ; Ira Shoulson	Familial paroxysmal dystonic choreoathetosis: A family study
004353 (1999)	Ira Shoulson	In memoriam

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/Author.i -k "Ira Shoulson" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/Author.i  \
                -Sk "Ira Shoulson" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Corpus
   |type=    indexItem
   |index=    Author.i
   |clé=    Ira Shoulson
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024